John Anderson, MD
Urology · Bethlehem, PANPI 1427012632
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $2,124,729 of the $2,124,941 with a category attached, or 100.0%. Cook Incorporated accounts for 100.0% of it on its own, with 2 other manufacturers making up the rest. Among urology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 17 payments — averaging $124,997 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cook Incorporated$2.1M
- Astellas Pharma US Inc$199
- Tolmar Pharmaceuticals, Inc.$13
What the payments were for
- Royalty or licence$2,124,729100%
- Food & beverage$1240%
- Education$880%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cook Incorporated | 5 | $2,124,729 |
| Astellas Pharma US Inc | 11 | $199 |
| Tolmar Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Cook$1,351,109
- Cook Medical Thoracic$773,620
How this compares
$2,124,941 in reported general payments places this provider in the 95th percentile of 596 urology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 36 | $28,048 |
| ElmironPentosan Polysulfate Sodium | 21 | $9,950 |
| Tamsulosin Hcl | 428 | $7,843 |
| Finasteride | 340 | $6,341 |
| Methenamine Hippurate | 57 | $2,917 |
| Potassium Citrate ErPotassium Citrate | 29 | $2,137 |
| Oxybutynin Chloride ErOxybutynin Chloride | 29 | $1,354 |
| NitrofurantoinNitrofurantoin Macrocrystal | 32 | $829 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 16 | $598 |
| Doxazosin Mesylate | 15 | $455 |
| Bicalutamide | 14 | $387 |
| Terazosin Hcl | 12 | $324 |
| Cephalexin | 46 | $318 |
| Nystatin-TriamcinoloneNystatin/Triamcinolone Acet | 22 | $316 |
| Ciprofloxacin Hcl | 80 | $278 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $199 | $28,04836 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 596 urology providers in Pennsylvania.
Other urology in Bethlehem
- Jatin GuptaBethlehem$25K
- Demetrius BagleyPhiladelphia$739K
- Paul SieberLancaster$631K
- Daniel EunPhiladelphia$226K
- Leonard GomellaPhiladelphia$190K
- Anthony DimatteoButler$189K
- Angelo BaccalaAllentown$166K
- Phillip GinsbergPhiladelphia$145K
- Edouard TrabulsiPhiladelphia$137K
- Siobhan HartiganPhiladelphia$121K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.